MTOR and glioblastoma: In glioblastoma, EPZ015666 overcame therapeutic resistance to the mTOR inhibitor PP242 via synergistic tumour inhibitory effects in vitro and xenograft mouse models in combination with the mTOR inhibitor PP242 (Holmes et al., 2019).